© 2017 by Calyptus  Pharmaceuticals Inc.

PARTNERING

We believe that combining our know-how with partners is key to creating shared success

Calyptus is constantly seeking and evaluating business development opportunities for sterile dosage forms. Opportunities of interest include:

 

  • Acquisition and in-licensing of ANDAs, 505(b)(2)s, established brands/NDAs

  • Co-development opportunities (ANDAs and 505(b)(2)s)

  • Out-licensing of select products for the U.S. and/or rest of world to commercial partners

For business development opportunities, please contact us using the email in the "Contact" tab of our webpage